Join the Exploding Neoantigen-Based Therapeutics Community
As the neoantigen space continues to evolve and mature, there are emerging challenges that have exposed the complexities of creating a truly individualized therapy that can target cancers.
The Neoantigen Based Therapies Summit is the leading end-to-end meeting dedicated to delivering the promise of accurate identification, prediction and validation of neoantigens to develop highly efficacious vaccines and cell therapies.
Top 5 reasons to attend:
Optimize novel neoantigen identification and prediction approaches with Genentech, Evaxion and Genocea to drive development of neoantigen based cancer therapeutics
Drive prediction accuracy through exploring and understanding the pros and cons of different neoantigen sources with Precision Biologics and Ervaxx
Generate stronger T cell responses and maximize immunogenicity with Gritstone Oncology and Treos Bio
Analyze and explore how neoantigens are being implemented into T cell therapies and cancer vaccines by delving into the clinical progress with Neon Therapeutics and Vaccibody
Reduce needle to needle time and overcome complex manufacturing challenges with Achilles Therapeutics, Vaximm and ISA Therapeutics